GLMD vs. IAK
GLMD (Galmed Pharmaceuticals Ltd.) is a stock, while IAK (iShares U.S. Insurance ETF) is Financials Equities fund tracking the Dow Jones U.S. Select Insurance Index. Over the past 10 years, GLMD returned -51.79%/yr vs 13.35%/yr for IAK. At a 0.09 correlation, their price movements are largely independent.
Performance
GLMD vs. IAK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLMD achieves a -28.47% return, which is significantly lower than IAK's 10.65% return. Over the past 10 years, GLMD has underperformed IAK with an annualized return of -51.79%, while IAK has yielded a comparatively higher 13.35% annualized return.
GLMD
- 1D
- -4.14%
- 1M
- -12.29%
- 6M
- -35.75%
- YTD
- -28.47%
- 1Y
- -72.26%
- 3Y*
- -68.64%
- 5Y*
- -74.30%
- 10Y*
- -51.79%
IAK
- 1D
- 1.42%
- 1M
- 9.44%
- 6M
- 12.05%
- YTD
- 10.65%
- 1Y
- 18.43%
- 3Y*
- 22.10%
- 5Y*
- 16.19%
- 10Y*
- 13.35%
GLMD vs. IAK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -28.47% | -76.47% | -41.58% | -93.93% | -72.53% | -41.48% | -46.19% | -15.37% | -25.36% | 160.68% |
IAK iShares U.S. Insurance ETF | 10.65% | 9.50% | 28.25% | 11.28% | 11.33% | 26.84% | -2.86% | 25.94% | -11.48% | 14.18% |
Correlation
The correlation between GLMD and IAK is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Mar 13, 2014 | 0.09 |
The correlation between GLMD and IAK shifts across timeframes, from -0.03 (3 years) to 0.09 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. IAK — Risk / Return Rank
GLMD
IAK
GLMD vs. IAK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and iShares U.S. Insurance ETF (IAK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | IAK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.98 | ||
| Sortino ratioReturn per unit of downside risk | -2.99 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.21 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | 2.43 | -3.34 |
| Martin ratioReturn relative to average drawdown | -1.19 | 5.95 | -7.15 |
Loading charts...
Drawdowns
GLMD vs. IAK - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, which is greater than IAK's maximum drawdown of -77.38%. Use the drawdown chart below to compare losses from any high point for GLMD and IAK.
Loading charts...
Drawdown Indicators
| GLMD | IAK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -77.38% | -22.61% |
Max Drawdown (1Y)Largest decline over 1 year | -79.86% | -7.62% | -72.24% |
Max Drawdown (3Y)Largest decline over 3 years | -97.30% | -11.58% | -85.72% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -14.76% | -85.16% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -44.95% | -55.04% |
Current DrawdownCurrent decline from peak | -99.98% | -0.03% | -99.95% |
Average DrawdownAverage peak-to-trough decline | -76.17% | -16.05% | -60.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.48% | 3.10% | +57.38% |
Volatility
GLMD vs. IAK - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 27.61% compared to iShares U.S. Insurance ETF (IAK) at 5.35%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than IAK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | IAK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.61% | 5.35% | +22.26% |
Volatility (6M)Calculated over the trailing 6-month period | 75.30% | 11.47% | +63.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 94.28% | 15.37% | +78.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.90% | 18.05% | +148.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.26% | 20.84% | +117.42% |
Dividends
GLMD vs. IAK - Dividend Comparison
GLMD has not paid dividends to shareholders, while IAK's dividend yield for the trailing twelve months is around 2.41%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IAK iShares U.S. Insurance ETF | 2.41% | 1.69% | 1.49% | 1.44% | 1.69% | 2.26% | 2.07% | 1.84% | 2.33% | 1.62% | 1.68% | 1.62% |
Frequently Asked Questions
GLMD and IAK have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (27.61%) compared to IAK (5.35%). In terms of maximum drawdown, GLMD dropped -99.99% vs IAK's -77.38%.
IAK currently has the higher Sharpe Ratio (1.21 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and IAK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer